Our assay prototypes are fully adaptable to your automated platforms
Our highly motivated, experienced R&D team is responsible for the whole process, from biomaterials design to assay prototype formulation and proof-of-concept on our chemiluminescence platform.
At OEM Technology Center we have developed assay and assay prototypes to be adapted to our OEM partners chemiluminescence platforms: Lyme disease (IgG, IgM and IgG+IgM), Parvovirus B19 (IgG and IgM), HTLV (IgG+IgM) assays, Next-gen Toxo IGM and AMH detection.
Assays for the detection of IgG, IgM and IgG+IgM antibodies to borrelia sp.
Assays for the detection of IgG and IgM antibodies to parvovirus B19
Assay for the detection of antibodies to HTLV-I/II
Assay for the measurement of IgG antibodies to measles virus
Assay for the measurement of IgG antibodies to mumps virus
Assays for the measurement of IgG and for the detection of IgM antibodies to varicella zoster virus
Please contact us directly via telephone or with the following form.
Tel. +34 93 860 90 00